Miri Ryu

Dr. Miri Ryu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SLSeungju Lee
Seungju Lee
HKHyun Yul Kim
Hyun Yul Kim
YJYOUNJOO JUNG
YOUNJOO JUNG
SKSeok-Kyung Kang
Seok-Kyung Kang
MRMiri Ryu
Miri Ryu
JKJee Yeon Kim
Jee Yeon Kim
Lee S, et al. J Breast Cancer. 2025 Nov;28:e43. https://doi.org/10.4048/jbc.2025.0165

8 August 2025 in Medicine
Verified
Journal Article
Open access
YJYOUNJOO JUNG
YOUNJOO JUNG
AKAyoung Kang
Ayoung Kang
MRMiri Ryu
Miri Ryu
SKSoo-Hong Kim
Soo-Hong Kim
JPJoon Young Park
Joon Young Park
Rationale: Myofibroblastoma is a rare, benign spindle cell tumor originating from the breast stroma. Although it predominantly affects older men and occasionally postmenopausal women, its occurrence in children is exceedingly rare. Patient concerns: A 5-year-old girl presented with a palpable mass on the lateral aspect of her left breast. Diagnoses: Serial ultrasound examinations were conducted every 6 months for 1 year because the lesion was initially suspected to be a lipoma or an enlarged lymph node. Interventions: Owing to progressive enlargement of the mass to 3 cm, surgical excision was performed. A well-defined yellow–white solid mass located in the subcutaneous layer was completely removed. Outcomes: The histopathological and immunohistochemical findings confirmed the diagnosis of a myofibroblastoma. The postoperative course was uneventful, and no recurrence has been reported to date. Lessons: Although extremely rare, myofibroblastoma should be considered in the differential diagnosis of enlarged breast masses in children. Complete surgical excision is the treatment of choice, and regular follow-up is recommended.

2 January 2026 in Children
Verified
Journal Article
Open access
PDF file
MRMiri Ryu
Miri Ryu
AKAyoung Kang
Ayoung Kang
SKSoo-Hong Kim
Soo-Hong Kim
Jae Hun ChungJae Hun Chung
Jae Hun Chung
HHHanpyo Hong
Hanpyo Hong
SSSoonki Sung
Soonki Sung
Background/Objectives: Hydrocephalus is primarily treated with open ventriculoperitoneal shunt (VPS) insertion, but laparoscopy-assisted VPS insertion has emerged as an alternative. This study compared outcomes and complications of laparoscopic versus open VPS insertion without a peel-away sheath in pediatric patients. Methods: A retrospective review was conducted on 121 VPS insertions (2012–2025) at a tertiary pediatric center in Korea. Patients were categorized into laparoscopic (n = 42) and open (n = 79) groups. The laparoscopic technique utilized only standard reusable instruments, without a peel-away sheath. Demographics, surgical parameters, postoperative recovery, and unplanned revision rates were analyzed. A Cox proportional hazards regression model was used to evaluate catheter survival, adjusting for baseline characteristics that differed significantly between the groups. Five-year shunt survival was assessed using Kaplan–Meier survival analysis. Results: The laparoscopic group had more revision cases and previous abdominal surgeries; additionally, intra-abdominal adhesions were more common (52.4% vs. 3.8%), and adhesiolysis was more often performed (9.5% vs. 1.3%). However, no differences were found in total operative time, distal catheter insertion time, or perioperative complications. After adjusting for demographic differences between the groups, Cox regression analysis demonstrated no significant difference in catheter survival. Both short-term (12 months) and long-term (5 years) shunt survival rates were comparable between the groups. Conclusions: Laparoscopic VPS insertion without a peel-away sheath is feasible and safe in pediatric patients, including those with complex surgical histories. It offers favorable recovery and adhesion management outcomes without compromising shunt durability, supporting its use as a practical alternative in resource-limited settings.

1 June 2026 in Gland Surgery
Verified
Journal Article
Open access
MRMiri Ryu
Miri Ryu
SLSeungju Lee
Seungju Lee
Transoral robotic thyroidectomy (TORT) relies on continuous carbon dioxide (CO2) insufflation to maintain the operative workspace, introducing a spectrum of gas-related complications. The newly introduced da Vinci 5 (DV5) system features an integrated, actively regulated insufflation and smoke evacuation system that differs fundamentally from prior-generation platforms. The platform-specific safety profile of the DV5 in TORT remains largely uncharacterized. A 50-year-old male with papillary thyroid carcinoma (PTC) of the left thyroid lobe underwent transoral robotic left hemithyroidectomy with central lymph node dissection using the DV5 system. Insufflation was maintained at 8 mmHg with a flow rate of 20 L/min; the procedure was uneventful. Upon post-anesthesia care unit (PACU) admission, the patient was stable (SpO2 99%), but developed acute chest pain and oxygen desaturation (SpO2 <90%) approximately 20 minutes later. Emergency chest radiography demonstrated bilateral pneumothorax requiring immediate bilateral chest tube insertion. Subsequent computed tomography (CT) confirmed pneumoretroperitoneum and pneumoperitoneum along the perirenal spaces without visceral injury, consistent with extensive CO2 migration along cervicofascial planes. The patient recovered with conservative management and was discharged without sequelae on postoperative day four. Final pathology confirmed pT1N0M0 PTC. Extensive multicavitary gas migration can occur following TORT even under standard insufflation settings and without direct organ injury. The DV5's integrated airflow regulation may alter intraoperative pressure gradients in way that differ from prior platforms. Surgeons adopting DV5 for TORT should consider reducing insufflation pressure to 6 mmHg, restricting automated smoke evacuation during deep dissection, and extending PACU monitoring for at least 60 minutes post-extubation. Multidisciplinary collaboration with system specialists is essential during platform adoption.

30 May 2026 in International Journal of Thyroidology
Verified
Journal Article
Open access
PDF file
SKSeok-Kyung Kang
Seok-Kyung Kang
MRMiri Ryu
Miri Ryu
MLMeehyun Lee
Meehyun Lee
HKHye Won Kim
Hye Won Kim
HHHanpyo Hong
Hanpyo Hong
SLSeungju Lee
Seungju Lee
Seok-Kyung Kang, Miri Ryu, Meehyun Lee, Hye Won Kim, Han Pyo Hong and Seungju Lee. Int J Thyroidol 2026;19:78-84. https://doi.org/10.11106/ijt.2026.19.1.78